Antidepressant therapy with duloxetine appears to be superior to paroxetine

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1316, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paroxetine "not superior" to placebo in major depression

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Dofetilide appears superior to amiodarone in HF

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Duloxetine: a new selective and dual-acting antidepressant

By Bauer Michael   Möller Hans-Jürgen   Schneider Edith  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 421-427

Informa Healthcare

Access to resources Recommend Favorite

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity

By Serretti A.   Zanardi R.   Cusin C.   Rossini D.   Lorenzi C.   Smeraldi E.  

European Neuropsychopharmacology, Vol. 11, Iss. 5, 2001-10 ,pp. : 375-380

Elsevier

Access to resources Recommend Favorite

Duloxetine has "an overall efficacy profile that is generally equivalent to fluoxetine and paroxetine"

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite